Condition

Pediatric SLE

ClinicalTrials.gov condition label

Clinical trials1

Recruiting0

Common interventions12

Lead sponsors shown1

Clinical trials

1 shown

COVID-19 Booster Vaccine in Autoimmune Disease Non-RespondersNCT05000216 · 2021-08-13

TERMINATED

Common interventions

Ad26.COV2.SBIOLOGICAL1BNT162b2BIOLOGICAL1BNT162b2, BivalentBIOLOGICAL1Continue IS (B cell depletion therapy)BIOLOGICAL1Continue IS (MMF or MPA)DRUG1Continue IS (MTX)DRUG1Moderna mRNA-1273BIOLOGICAL1Moderna mRNA-1273, BivalentBIOLOGICAL1Monovalent [B.1.351] CoV2 preS dTM-AS03BIOLOGICAL1Withhold IS (B cell depletion therapy)DRUG1Withhold IS (MMF or MPA)DRUG1Withhold IS (MTX)DRUG1

Leading sponsors

National Institute of Allergy and Infectious Diseases (NIAID)1

Trial status mix

TERMINATED1

Phase mix

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.